Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (3974)	12/21/1997 10:39:00 PM
From: blankmind	Read Replies (1) \| Respond to of 23519

-- Does anyone know how many dosages in a prescription of MUSE? -- Out.

To: James Baker who wrote (3974)	12/27/1997 11:00:00 AM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 23519

Nice analysis Jim of the Barron's article.It is really surprising that Barron's Editors allowed this guy,( Bill Alpert ) , to quote the OPINION (no published data ) of a SINGLE guy ( Barada ), as to how effective MUSE is, and to totaslly neglect all other published data. Does anybody have any suspicion by now, ( after 7 months of ED data from Barrons ), that Barrons must be running a covert Shorts- mill in their backrooms? < GGG>. ( Just a joke, don't get ansi ). TA